Argá Medtech
Novel Sine Wave Technology Promises Significant Advantages Over Existing Pulsed Field Cardiac Ablation Systems
$58.72M Series B+ ·
Led by Advent Life Sciences · Source: Greater Geneva Bern area (GGBa)
Funding history ↓Signals
X account@argamedtech · created Apr 27, 2022 (4 years old) · 23 followers
Website registeredOct 8, 2019 (7 years old)
Funding rounds
- Series B+ · $58.72MSource: Greater Geneva Bern area (GGBa)
- X account created
- Website created
Founders and team
DN
David Neale FounderRW
Randy Werneth Founder
Investors
Companies like Argá Medtech
WWobble Genomics$1.66M Seed · Sep 2021AAnaCardio$70.97M Series B+ · Sep 2026
SSecretome Therapeutics$30M Series A · May 2026TThe General Intelligence Company$8.7M Series A · Dec 2025
33T Biosciences$40M Series A · Aug 2022
VVergeSeries A · Apr 2022
Other companies backed by Advent Life Sciences
TT-Therapeutics$133M Series B+ · Nov 2026
GGlycomine$115M Series B+ · May 2025
EEpitopea$31M Series A · Oct 2024
FF2G$100M Series B+ · Sep 2024
PProximieSeries B+ · Sep 2024
Advent Life Sciences portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/arga-medtech (get a free API key).